Avian influenza: An emerging pandemic threat

Cleveland Clinic Journal of Medicine

Volumn 72, Issue 12, 2005, Pages 1129-1134

  Jin, Xian Wen ^a   Mossad, Sherif B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; OSELTAMIVIR; VIRUS VACCINE; ZANAMIVIR;

ANTIGENICITY; ARTICLE; ASIA; AVIAN INFLUENZA; DRUG EFFICACY; DRUG MECHANISM; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HISTORY OF MEDICINE; HUMAN; INFECTION PREVENTION; INFLUENZA VIRUS; MORTALITY; STRAIN DIFFERENCE; VIRUS STRAIN; VIRUS TRANSMISSION; DISEASE TRANSMISSION; INFLUENZA; INFLUENZA VIRUS A H5N1; PHYSIOLOGY; REVIEW;

DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN;

EID: 33644851757     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.72.12.1129     Document Type: Article

References (33)

1. Horimoto T, Kawaoka Y. influenza: lessons from past pandemics, warnings from current incidents. Nat Rev: Microbiol 2005; 3:591-600.
2. Monto AS. The threat of an avian influenza pandemic. N Engl J Med 2005; 352:323-325.
3. Scholtissek C, Rohde W, Von Hoyningen V, Rott R. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 1978; 87:13-20.
4. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989; 63:4603-4608.
5. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1978, 178:53-60.
6. Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996; 18:64-76.
7. Reid AH, Taubenberger JK, Fanning TG. Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus. Nat Rev Microbiol 2004; 2:909-914.
8. Tumpey TM, Basler CF, Aguilar PV, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005; 310:77-80.
9. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. Characterization of the 1918 influenza virus polymerase genes. Nature 2005; 437:889-893.
10. Centers for Disease Control and Prevention. Recent avian influenza outbreaks in Asia and Europe. www.cdc.gov/flu/avian/outbreaks/ asia.htm#recent. Accessed November 7, 2005.
11. Liu J, Xiao H, Lei F, et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. Science 2005; 309:1206.
12. World Organization for Animal Health. www.oie.int/downld/ AVIAN%20INFLUENZA/A_Al_Asia.htm. Accessed November 14, 2005.
13. Tran TH. Nguyen TL, Nguyen TD, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350:1179-1188.
14. Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351:467-471.
15. World Health Organization. Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO, November 9, 2005. (Accessed November 14, 2005, at http:/www.who.int/csr/disease/avian_influenza/ country/cases_table_2005_11_09/en/index.html.)
16. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005; 352:333-340.
17. Subbarao K, Klimov A, Katz J, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998, 279:393-396.
18. Claas EC, Osterhaus AD, van Beek R, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998, 351:472-477.
19. Hatta M, Gao P, Halftmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001; 293:1840-1842.
20. Shinya K, Hamm S, Hatta M, Ito H, Ito T, Kawaoka Y. PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology 2004; 320:258-266.
21. Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 2002; 8:950-954.
22. Seo SH, Hoffmann E, Webster RG. The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. Virus Res 2004; 103:107-113.
23. Cheung CY, Poon LL, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360:1831-1837.
24. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004, 363:617-619.
25. Beigel JH, Farrar J. Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353:1374-1385.
26. Centers for Disease Control and Prevention. Outbreak notice update: human infection with avian influenza a (H5N1) virus in Asia. www.cdc.gov/ travel/other/avian_influenza_se_asia\2005.htm. Accessed November 7, 2005.
27. Centers for Disease Control and Prevention. Outbreak notice update: guidelines and recommendations. Interim guidance about avian influenza (H5N1) for U.S. Citizens Living Abroad. October 26, 2005. www.cdc.gov/ travel/other/avian_flu_ig_americans_abroad_032405.htm. Accessed November 14, 2005.
28. World Health Organization. WHO recommendations relating to travelers coming from and going to countries experiencing outbreaks of highly pathogenic H5N1 avian influenza. www.whoint/csr/disease/avian_influenza/ travel/2005_11_3/en/. Accessed November 14, 2005.
29. Wang C, Takeuchi K, Pinto LH, Lamb RA. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol 1993; 67:5585-5594.
30. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005; 353:1363-1373.
31. Hayden FG. Pandemic influenza: is an antiviral response realistic? Pediatr Infect Dis J 2004, 23(suppl):S262-S269.
32. Mai Le Q. Kiso M, Someya K, et al. Avian flu. Isolation of drug-resistant H5N1 virus (brief communication). Nature 2005; 437:1108.
33. World Health Organization. Scientists at the National Institute of Allergy and Infectious Disease announce results of clinical trials of H5N1 avian influenza vaccine. www.who.int/csr/disease/avian_influenza/ statement_2005_08_12/en/index.html. Accessed October 24, 2005.